Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study

OBJECTIVES: Gonadotropin-releasing hormone (GnRH) stimulates immune responses; therefore, antagonizing GnRH with cetrorelix may have anti-inflammatory effects. The aim of this study was to assess short-term cetrorelix therapy in rheumatoid arthritis (RA) patients. METHOD: In this proof-of-concept, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kåss, AS, Førre, ØT, Fagerland, MW, Gulseth, HC, Torjesen, PA, Hollan, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913106/
https://www.ncbi.nlm.nih.gov/pubmed/24182325
http://dx.doi.org/10.3109/03009742.2013.825007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913106/
https://www.ncbi.nlm.nih.gov/pubmed/24182325
http://dx.doi.org/10.3109/03009742.2013.825007

Ejemplares similares